Leukotriene E4 ≥98%

Supplier: Enzo Life Sciences
Danger

BML-LE004-0050 BML-LE004-1000
89160-514EA 469.26 CAD
89160-514 89160-516
Leukotriene E4 ≥98%
Leukotriene E4

Prostanoid receptor ligand.


  • Formulation: Liquid.


Less potent than LTD4 in smooth muscle contractile activity and mucus secretion in airways. Reduces myocardial contractility and coronary blood flow. Induces long lasting hypotension and airway hyperresponsiveness. Partial agonist at LTD4 receptors. LTE4 solely activates a CysLT1 receptor. Biosynthesis from LTD4 by a dipeptidase.

Formula: C₂₃H₃₇NO₅S
MW: 439.6 g/mol
Storage Temperature: Ultra-Low Temperature Freezer (–80°C)
CAS Number: 75715-89-8
UN: 1992
ADR: 3 II
https://digitalassets.avantorsciences.com/adaptivemedia/rendition?id=620a9bd70d9e5c33f1342742ad3c988167d9015e&vid=18cfadcf0d357f83801f60d1b1d06b698bcf2a10&prid=web&clid=SAPDAM

Order Now

Specification Test Results

Concentration 50 µg/mL
Formulation Solution in methanol/ammonium acetate buffer, 70:30, pH 5.6.
Purity ≥98% (HPLC)


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR